硕世生物
(688399)
| 流通市值：39.71亿 | | | 总市值：39.71亿 |
| 流通股本：5667.01万 | | | 总股本：5667.01万 |
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 每股收益(元) | 0.23 | -0.03 | 0.46 | 0.50 | 0.68 | -6.38 | -3.00 | -1.17 |
| 每股净资产(元) | 57.59 | 57.36 | 56.07 | 58.59 | 58.77 | 58.09 | 61.46 | 63.30 |
| 每股资本公积金(元) | 11.67 | 11.67 | 13.79 | 13.76 | 13.76 | 13.76 | 13.76 | 13.76 |
| 每股未分配利润(元) | 44.49 | 44.27 | 43.29 | 43.33 | 43.51 | 42.83 | 46.20 | 48.04 |
| 每股经营性现金流(元) | 0.08 | 2.58 | 1.65 | 1.27 | 0.90 | -1.93 | -4.73 | -6.64 |
| 净资产收益率(%) | 0.39 | -0.06 | 0.80 | 0.86 | 1.17 | -10.41 | -4.77 | -1.82 |
| 营业总收入(元) | 9160.84万 | 3.50亿 | 2.68亿 | 1.77亿 | 9111.94万 | 4.03亿 | 2.76亿 | 1.87亿 |
营业总收入同比增长(%) | 0.54 | -13.29 | -3.02 | -4.91 | -3.12 | -92.72 | -93.56 | -94.29 | | 归属净利润(元) | 1281.94万 | -200.17万 | 2711.47万 | 2924.05万 | 4006.80万 | -37381.14万 | -17601.43万 | -6829.47万 |
| 归属净利润同比增长(%) | -68.01 | 99.46 | 115.40 | 142.82 | 306.28 | -120.45 | -110.84 | -105.54 |
| 扣非净利润(元) | -558.05万 | -7183.71万 | -1646.51万 | -212.52万 | 1487.41万 | -42920.11万 | -20529.74万 | -9168.52万 |
|
| 扣非净利润同比增长(%) | -137.52 | 83.26 | 91.98 | 97.68 | 143.37 | -124.31 | -112.79 | -107.50 |
| 毛利率(%) | 57.93 | 62.26 | 65.66 | 68.13 | 70.93 | 63.91 | 60.12 | 64.74 |
| 净利率(%) | 13.99 | -0.57 | 10.11 | 16.48 | 43.97 | -92.72 | -63.67 | -36.60 |
| 资产负债率(%) | 15.66 | 13.08 | 14.78 | 14.23 | 14.58 | 12.83 | 15.94 | 14.69 |
| 存货周转率(次) | 0.61 | 1.64 | 0.95 | 0.59 | 0.27 | 0.88 | 0.53 | 0.28 |